Pfizer Inc. vs Gilead Sciences, Inc.
Market cap comparison over time
Pfizer Inc.
$149.2B
Rank #104
Gilead Sciences, Inc.
$156.3B
Rank #99
Market Cap Over Time
Key Moments
- Gilead Sciences, Inc. overtook Pfizer Inc. by 2025
Year-by-Year Comparison
| Year | Pfizer Inc. | Gilead Sciences, Inc. | Leader |
|---|---|---|---|
| 2026 | $149.2B | $156.3B | Gilead Sciences, Inc. |
| 2025 | $137.3B | $150.5B | Gilead Sciences, Inc. |
| 2024 | $136.4B | $110.0B | Pfizer Inc. |
| 2023 | $139.5B | $92.6B | Pfizer Inc. |
| 2022 | $237.5B | $94.6B | Pfizer Inc. |
| 2021 | $265.1B | $76.4B | Pfizer Inc. |
| 2020 | $159.1B | $58.7B | Pfizer Inc. |
| 2019 | $154.3B | $63.0B | Pfizer Inc. |
| 2018 | $165.8B | $58.5B | Pfizer Inc. |
| 2017 | $132.8B | $65.0B | Pfizer Inc. |
| 2016 | $114.6B | $63.2B | Pfizer Inc. |
| 2015 | $109.7B | $87.4B | Pfizer Inc. |
| 2014 | $102.5B | $80.8B | Pfizer Inc. |
| 2013 | $97.3B | $64.4B | Pfizer Inc. |
| 2012 | $77.1B | $31.5B | Pfizer Inc. |
| 2011 | $64.0B | $17.6B | Pfizer Inc. |
| 2010 | $49.7B | $15.5B | Pfizer Inc. |
| 2009 | $49.6B | $18.6B | Pfizer Inc. |
| 2008 | $45.8B | $21.9B | Pfizer Inc. |
| 2007 | $55.2B | $19.7B | Pfizer Inc. |
| 2006 | $60.1B | $13.9B | Pfizer Inc. |
| 2005 | $52.1B | $11.3B | Pfizer Inc. |
| 2004 | $58.3B | $7.5B | Pfizer Inc. |
| 2003 | $75.0B | $6.2B | Pfizer Inc. |
| 2002 | $63.7B | $3.6B | Pfizer Inc. |
| 2001 | $81.9B | $3.5B | Pfizer Inc. |
| 2000 | $93.5B | $2.2B | Pfizer Inc. |
| 1999 | $65.4B | $1.5B | Pfizer Inc. |
| 1998 | $83.3B | $1.1B | Pfizer Inc. |
| 1997 | $49.3B | $1.0B | Pfizer Inc. |
| 1996 | $27.1B | $670.1M | Pfizer Inc. |
| 1995 | $20.2B | $857.7M | Pfizer Inc. |
| 1994 | $12.1B | $254.6M | Pfizer Inc. |